Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Rising to the medication's requirements

The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics field

Bibliographic Data

ID4591845
AuthorsRose-Anna Foley (0000-0001-5928-2928, Centre universitaire de médecine générale et santé publique, Lausanne), Lucie Lechevalier Hurard (HES-SO University of Applied Sciences and Arts Western Switzerland), Annick Anchisi (HES-SO University of Applied Sciences and Arts Western Switzerland), Sandro Anchisi (0000-0002-8060-6349, Hôpital du Valais)
Year2019
Volume242
Pages112593
Publication date2019-12-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueSocial Science & Medicine (JOURNAL)
Journal identifiersISSN: 0277-9536 • E-ISSN: 1873-5347
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.socscimed.2019.112593
PMID31629159
OpenAlexW2980292049
LanguageEN
References cited42

A new subfield of oncology has emerged in the last twenty years to raise awareness and address the specific needs of elderly cancer patients, a population that was long neglected in oncology. We sought to understand the individual experiences, as well as moral and social implications of considering elderly cancer patients as "treatable". Following an anthropological critical interpretative approach focusing on practical and symbolic effects of chemotherapy in a rapidly evolving medical field, we conducted 20 semi-structured interviews and observations of medicine storage places at home among elderly cancer patients aged 70 and over in a clearly incurable situation receiving palliative chemotherapy. We used photographs representing paths as triggers in interviews, and compared the patients' views with those of 12 health professionals in oncology during a brief open-ended interview. Elderly cancer patients consider themselves to be survivors and fighters. Their long trajectory is a result of their successful struggle and tolerance of the treatments allowing them to carry on. They continually observe their physical ability and test their resistance, they resist complaining and are grateful to have cancer at a late stage of life. By highlighting their active life rather than the treatment inconveniences, they show they are "young elderly" persons, capable of keeping active physically. They are treated precisely because they demonstrated that they had the physical and moral capacity to take the hit of the chemotherapy to their bodies and had the will to fight. The development of oncogeriatrics has enabled the treatment of the fittest cancer patients over 70, but the ethical debate to treat some elderly patients and not others, and decisions of therapeutic abstention facing frail elderly cancer patients remains an issue rarely discussed. This aspect should not be eluded by the important progress achieved in medicine facing cancer

Cancer · Family medicine · Geriatric oncology · Palliative care · Population · Quality of life (healthcare · Cancer survivorship and care · Medicine · Nursing · Palliative Care and End-of-Life Issues · Patient Dignity and Privacy · Gerontology · Internal Medicine

  • Cancer Disparities by Race/Ethnicity and Socioeconomic Status

    Open Access•Elizabeth Ward, Ahmedin Jemal et al.•CA: A Cancer Journal for Clinicians•2004

  • Visual anthropology

    John Collier•Visual anthropology•1986

  • Medicine, Rationality and Experience

    Open Access•B J Good•Medicine, Rationality and…•1993

  • Le « moral » en cancérologie Stratégies et discours des soignants dans l’accompagnement des malades

    Open Access•Fanny Soum-Pouyalet, Anne Vega et al.•Psycho-Oncologie•2009

  • Discourse, knowledge and experience of cancer

    Open Access•Francine Saiillant•Culture Medicine and Psychiatry•1990

  • American oncology and the discourse on hope

    Open Access•Mary‐jo Del Vecchio Good, Mary-Jo Del Vecchio Good et al.•Culture Medicine and Psychiatry•1990

  • Medicine, rationality, and experience

    Open Access•Isabel Dyck•Health & Place•1995

  • Expériences temporelles au grand âge

    Monique Membrado, Tristan Salord•Journal of Evidence-Informed…•2009

  • Le traitement adjuvant du cancer du sein par tamoxifène

    Aline Sarradon-Eck, Isabelle Pellegrini•Sciences sociales et santé•2012

  • Le traitement adjuvant du cancer du sein par tamoxifène. Entre risques et bénéfices thérapeutiques

    Aline Sarradon-Eck, Isabelle Pellegrini•Sciences sociales et santé•2012

  • Toward a history and anthropology of the iatrogenic effects of the "fight" against disease

    Open Access•Marie Christine Pouchelle•Asclepio•2002

  • Liminality

    Open Access•Miles Little, Christopher F C Jordens et al.•Social Science & Medicine•1998

  • Shades of blue

    Open Access•Jessica H Muller, Jessica Müller•Social Science & Medicine•1992

  • The negotiation of death

    Open Access•Jacquelyn Slomka•Social Science & Medicine•1992

  • Le risque en santé publique

    Raymond Massé•Sociologie et sociétés•2008

  • Les recompositions du « faire mourir

    Dominique Memmi, Emmanuel Taïeb•Sociétés contemporaines•2009

  • Médicaments, drogues et poisons

    Jean-Pierre Peters, Jean-Pierre Peter•Ethnologie française•2004

  • Les médicaments dans l'espace privé

    Sylvie Fainzang•Anthropologie et Sociétés•2004

  • Popularité et scepticisme

    Van Der Geest, Sjaak Van Der Geest et al.•Anthropologie et Sociétés•2004

  • Mourir à l'heure du médecin

    Nancy Kentish-Barnes, Nancy Kentish‐Barnes•Revue Française de Sociologie•2007

  • Les temps du cancer

    Danièle Carricaburu, Marie Ménoret•Revue Française de Sociologie•2000

  • Social Death as Self-Fulfilling Prophecy

    Open Access•Stefan Timmerman, Stefan Timmermans•Sociological Quarterly•1998

Citation velocityhistorical
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae